Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A comparison of methods for adaptive sample size adjustment.

T Friede1, M Kieser

  • 1Medical Biometry Unit, University of Heidelberg, Im Neuenheimer Feld 305, 69120 Heidelberg, Germany.

Statistics in Medicine
|January 10, 2002
PubMed
Summary

Recalculating clinical trial sample sizes efficiently does not require unblinding treatment codes. Blinded sample size recalculation procedures are as effective as those requiring unblinding, simplifying trial management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem‑ion): Interim report of a randomized phase II pilot trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Interprofessional communication in the ambulatory health sector in Germany: a multi-perspective cross-sectional study (<i>interprof</i> HOME).

Journal of interprofessional care·2025
Same author

Transgenerational transmission of psychopathology: when are adaptive emotion regulation strategies protective in children?

Child and adolescent psychiatry and mental health·2024
Same author

Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trial.

BMC cancer·2022
Same author

Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem-ion): study protocol for a randomized phase II pilot trial.

BMC cancer·2022
Same author

Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial.

Trials·2021

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Medical Research Methodology

Background:

  • Accurate sample size determination is crucial for fixed sample size clinical trials.
  • Internal pilot study designs allow for sample size adjustments using interim variance estimates.
  • Traditional internal pilot studies necessitate unblinding treatment codes, which is often undesirable.

Purpose of the Study:

  • To compare the efficiency of sample size recalculation procedures with and without unblinding.
  • To evaluate the impact of early stopping options on sample size variability.
  • To determine if unblinding is necessary for effective sample size adjustments in clinical trials.

Main Methods:

  • Simulation studies were conducted to compare various sample size recalculation procedures.

Related Experiment Videos

  • Procedures with and without unblinding were assessed for their performance.
  • Study designs incorporating early stopping were also evaluated alongside pure sample size adaptation methods.
  • Main Results:

    • Simulation results demonstrated that sample size recalculation procedures perform similarly, regardless of whether treatment codes are unblinded.
    • Breaking the blind is not a prerequisite for efficient sample size adjustment.
    • Early stopping options can reduce the expected sample size but increase its variability.

    Conclusions:

    • Blinded sample size recalculation is a viable and efficient alternative to unblinded methods.
    • Clinical trial designs can achieve effective sample size adjustments without compromising treatment group blinding.
    • The choice between pure sample size adaptation and early stopping depends on the desired balance between expected sample size and its variability.